Overview

We are conducting clinical trials with our four SPEAR T-cells therapies (ADP-A2M4, ADP-A2AFP, ADP-A2M4CD8 and ADP-A2M10) in ten cancers. The purpose of this section is to serve as an introduction for patients who might be interested in our current trials. Below is a list of the trials we are conducting with links to the clinicaltrials.gov pages, where you can find more details about each trial including participating clinical trial sites.

In each section, you will also find information about the various cancer types we are investigating, details about participating in our trials, and what will happen if you take part.

For more details on the technology, development, and product pipeline, please visit the corresponding pages on our site.

For patient inquiries, please contact patients@adaptimmune.com

ADP-A2M4 Phase 1 trial: Multiple Solid Tumors

This clinical trial is looking for patients in 9 different tumor types (click on the links to find more information about each cancer):

For more information about the trial and participating clinical trial centers, please click the button below that will take you to clinicaltrials.gov.

View Clinical Trial

ADP-A2M10 Phase 1 trial: Bladder, Melanoma, H&N

This clinical trial is looking for patients in 3 different tumor types (click on the links to find more information about each cancer):

For more information about the trial and participating clinical trial centers, please click the button below that will take you to clinicaltrials.gov.

View Clinical Trial

ADP-A2M10 Phase 1 study: Non-Small Cell trial Cancer

This Phase 1/2 clinical trial is looking for patients with advanced stage NSCLC (click on the link to find more information about NSCLC cancer).

For more information about the trial and participating clinical trial centers, please click the button below that will take you to clinicaltrials.gov.

View Clinical Trial

ADP-A2AFP Phase 1 trial: Liver Cancer

This Phase 1 clinical trial is looking for patients who have liver cancer (click on the link to find more information about liver cancer).

For more information about the trial and participating clinical trial centers, please click the button below that will take you to clinicaltrials.gov.

View Clinical Trial